At HuaTeng Biotechnology, we go beyond generating data — we deliver reliable, decision-ready results to support your therapeutic and diagnostic development.

We understand that successful development depends on the translational relevance of preclinical models and the quality of data submitted to global regulators. By combining clinically relevant disease models with our AAALAC-accredited and GLP-compliant platform, we help improve study reliability and accelerate R&D timelines.

Whether supporting IND-enabling studies for novel drugs or conducting preclinical evaluation for Class III medical devices, our team ensures studies are executed with consistency, scientific rigor, and regulatory awareness.

With experience from over 3,000 CRO projects and support for 300+ regulatory submissions, we provide proven capabilities to advance your programs with confidence.